Sanofi logo

Sanofi dividendNASDAQ: SNY

TTMAnnual

Dividend per share (last paid)

$2.04
+$0.14+7.23%

09 May 2024

Dividend per share (next)

-

new highvs 3 years high
+585.53%vs 3 years low
Performance
Most recent+7.2%
1 year+7.2%
3 years+5.6%
5 years+17.1%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend per share (last paid) performance

Most recent change
SNY+7.2%
BSX-
SYK0.0%
VRTX-
MDT0.0%
GILD0.0%
BMY0.0%
1 year change
SNY+7.2%
BSX-
SYK+6.7%
VRTX-
MDT+1.4%
GILD+2.7%
BMY+5.3%
3 years change
SNY+5.6%
BSX-
SYK+27.0%
VRTX-
MDT+11.1%
GILD+8.4%
BMY+22.4%
5 years change
SNY+17.1%
BSX-
SYK+53.9%
VRTX-
MDT+29.6%
GILD+22.2%
BMY+46.3%

Dividend per share (last paid) performance

SNYBSXSYKVRTXMDTGILDBMY
Most recent+7.2%-0.0%-0.0%0.0%0.0%
1 year+7.2%-+6.7%-+1.4%+2.7%+5.3%
3 years+5.6%-+27.0%-+11.1%+8.4%+22.4%
5 years+17.1%-+53.9%-+29.6%+22.2%+46.3%
FAQ

What is Sanofi dividend per share (last paid)?

Sanofi dividend per share (last paid) is $2.04

What is Sanofi dividend per share (last paid) compared to its all-time maximum value?

Sanofi dividend per share (last paid) is 100% of its all-time maximum value

How has Sanofi dividend per share (last paid) changed over the year?

Over the past year, Sanofi dividend per share (last paid) has increased by 7.2%. During the same period, , Stryker has risen by 6.7%, Medtronic has increased by 1.4%, Gilead Sciences has risen by 2.7%, Bristol-Myers Squibb has grown by 5.3%

How has Sanofi dividend per share (last paid) changed over the 3 years?

During the last 3 years, Sanofi dividend per share (last paid) has increased by 5.6%. Over the same period, , Stryker has risen by 27.0%, Medtronic has increased by 11.1%, Gilead Sciences has risen by 8.4%, Bristol-Myers Squibb has grown by 22.4%

How has Sanofi dividend per share (last paid) changed over the 5 years?

For the past 5 years, Sanofi dividend per share (last paid) has increased by 17.1%. In the same period, , Stryker has risen by 53.9%, Medtronic has increased by 29.6%, Gilead Sciences has risen by 22.2%, Bristol-Myers Squibb has grown by 46.3%